25 LLC’s Medtronic MDT Stock Holding History

25 LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-97	Closed	-$8.52K	–	329
2023 Q2	$8.52K	Buy	97 +6	+7%	+$517	﹤0.01%	159
2023 Q1	$8.18K	Buy	+91	New	+$7.42K	0.01%	157

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

25 LLC's MDT Position: Q3 2023 in Review

25 LLC sold out of Medtronic (MDT) in Q3 2023, closing a stake of 97 shares — an estimated $8.52K sold.

25 LLC first reported a position in MDT in Q1 2023 and held it in 2 quarters. The position peaked at $8.52K in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

25 LLC reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
25 LLC sold 97 Medtronic shares in Q3 2023, an estimated $8.52K.
25 LLC first reported a position in Medtronic in Q1 2023 and held it in 2 quarters.
25 LLC's Medtronic position peaked at $8.52K in Q2 2023.
1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.